Sodium-glucose cotransporter 2 inhibitors in patients with transthyretin amyloid cardiomyopathy - results from a patient series

被引：0
|
作者：
Alves Da Silva, P. Pedro [1 ]
Agostinho, J. R. [1 ]
Brito, J. [1 ]
Valente-Silva, B. [1 ]
Garcia, A. B. [1 ]
Oliveira, C. [1 ]
Martins, A. M. [1 ]
Raposo, M. [1 ]
Gregorio, C. [1 ]
Morais, P. [1 ]
Conceicao, I. [1 ]
Brito, D. [1 ]
Pinto, F. J. [1 ]
机构：
[1] Santa Maria Univ Hosp, CHLN Lisbon Acad Med Ctr, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
    Porcari, Aldostefano
    Cappelli, Francesco
    Nitsche, Christian
    Tomasoni, Daniela
    Sinigiani, Giulio
    Longhi, Simone
    Bordignon, Luca
    Masri, Ahmad
    Serenelli, Matteo
    Urey, Marcus A.
    Musumeci, Beatrice
    Cipriani, Alberto
    Canepa, Marco
    Eslam, Roza Badr
    Kronberger, Christina
    Chimenti, Cristina
    Zampieri, Mattia
    Allegro, Valentina
    Razvi, Yousuf
    Patel, Rishi
    Ioannou, Adam
    Rauf, Muhammad U.
    Petrie, Aviva
    Whelan, Carol
    Emdin, Michele
    Metra, Marco
    Merlo, Marco
    Sinagra, Gianfranco
    Hawkins, Philip
    Solomon, Scott
    Gillmore, Julian
    Fontana, Marianna
    CIRCULATION, 2023, 148 (25) : E303 - E303
  • [2] Sodium-glucose cotransporter 2 inhibitors use and outcomes in transthyretin amyloid cardiomyopathy
    Jaiswal, Vikash
    Hanif, Muhammad
    Jaiswal, Akash
    Sundas, F. N. U.
    Mattumpuram, Jishanth
    Fonarow, Gregg
    CIRCULATION, 2024, 150
  • [3] Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy
    Maccallini, M.
    Barge-Caballero, G.
    Barge-Caballero, E.
    Lopez-Canoa, J. N.
    Enriquez-Vazquez, D.
    Couto-Mallon, D.
    Paniagua-Martin, M. J.
    Vazquez-Rodriguez, J. M.
    Crespo-Leiro, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 362 - 362
  • [4] Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy
    Nalbandian, A.
    Teruya, S.
    Smiley, D.
    Helmke, S.
    Yarmohammadi, H.
    Maurer, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 35 - 36
  • [5] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy
    Byer, Stefano H.
    Sivamurugan, Aravinthasamy
    Grewal, Udhayvir S.
    Fradley, Michael G.
    Dominic, Paari
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 243 : 15 - 18
  • [6] Sodium-glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: Analyses of short-term efficacy and safety
    Lang, Frederick M.
    Teruya, Sergio
    Weinsaft, Ariel
    Cuomo, Margaret
    Santos, Alfonsina Mirabal
    Nalbandian, Ani
    Bampatsias, Dimitrios
    Maurer, Mathew S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 938 - 947
  • [7] Sodium-glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta-analysis
    Karakasis, Paschalis
    Theofilis, Panagiotis
    Patoulias, Dimitrios
    Schuermans, Art
    Vlachakis, Panayotis K.
    Klisic, Aleksandra
    Rizzo, Manfredi
    Fragakis, Nikolaos
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025,
  • [8] The changing landscape of heart failure treatment in transthyretin amyloid cardiomyopathy: Is the time ripe for clinical use of sodium-glucose cotransporter 2 inhibitors?
    Porcari, Aldostefano
    Fontana, Marianna
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 948 - 951
  • [9] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
  • [10] SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN PATIENTS WITH ALPORT SYNDROME AND FSGS: A CASE SERIES
    Boeckhaus, Jan
    Gross, Oliver
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I753 - I754
12345